Le Moigne, R. et al. Preclinical and clinical pharmacology of EPI-7386, an androgen receptor N-terminal domain inhibitor for castration-resistant prostate cancer. ASCO GU 2021. (Abstract Number: 119).

Read More > ASCO-GU Poster Presentation